NCT03105414

Brief Summary

Rationale : ventilator associated pneumonia (VAP) has been extensively studied in adults, however, few data exist regarding VAP in the paediatric intensive care population. The Centers for Disease Control (CDC) definition for VAP is regularly updated trying to homogenised practice, and the last version for paediatrics has been published in 2015. According to the latest CDC definition, the investigators aim to study incidence of VAP in different paediatric intensive care units (PICUs), diagnostic methods of identifying VAP, microbiology of VAP, and utilisation of empirical antimicrobial therapy. Methods and population : a prospective multicentre observational study will be conducted in European PICUs for one year. All patients admitted to PICU aged more than 28 days and \< 18 years, mechanically ventilated either by endotracheal or tracheostomy tube are included. Clinical data, ventilation settings, and risk factors for VAP are inserted daily in an electronic database on the internet. The investigators are going to identify patients, who presented one or more episodes of VAP during PICUs stay, analysing onset circumstances, diagnostic methods, bacteria pathogens identified, and antibiotic treatment. VAP incidence will be reported as number of events per 1,000 ventilator-days. Risk factors associated to VAP will be identified by univariate and multivariate analysis. Results and perspective : the investigators aim to define for the first time the incidence of VAP among European PICUs with a prospective and multicentre study. The identification of risk factors, diagnostic methods, epidemiology, treatment strategies will define the basis to start prevention manoeuvres and improve the clinical strategies for VAP in paediatric intensive care population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,100

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 4, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 10, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2019

Completed
Last Updated

May 9, 2017

Status Verified

May 1, 2017

Enrollment Period

1.1 years

First QC Date

April 4, 2017

Last Update Submit

May 8, 2017

Conditions

Keywords

Mechanical ventilationPediatricsCross infectionIntensive careDiagnosis

Outcome Measures

Primary Outcomes (1)

  • Incidence of ventilator acquired pneumonia

    CDC definition of ventilator acquired pneumonia

    Until weaning of ventilator or 1 year

Secondary Outcomes (2)

  • Bacteria prevalence of ventilator acquired pneumonia

    Until weaning of ventilator or 1 year

  • prevalence of diagnostic devices used to identify ventilator acquired pneumonia

    Until weaning of ventilator or 1 year

Interventions

Mechanical ventilation

Eligibility Criteria

Age28 Days - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

All patients admitted to Pediatric Intensive Care Unit aged more than 28 days and \< 18 years, mechanically ventilated either by endotracheal or tracheostomy tube are included. Clinical data, ventilation settings, and risk factors for VAP are inserted daily in an electronic database on the internet.

You may qualify if:

  • Admitted to Pediatric Intensive Care Unit
  • Aged more than 28 days and \< 18 years
  • Mechanically ventilated either by endotracheal or tracheostomy tube

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Robert Debré Hospital

Paris, 75019, France

RECRUITING

MeSH Terms

Conditions

Pneumonia, Ventilator-AssociatedCross InfectionDisease

Interventions

Respiration, Artificial

Condition Hierarchy (Ancestors)

Healthcare-Associated PneumoniaInfectionsPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Airway ManagementTherapeuticsResuscitationEmergency TreatmentRespiratory Therapy

Central Study Contacts

Stéphane Dauger, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 4, 2017

First Posted

April 10, 2017

Study Start

April 3, 2017

Primary Completion

May 15, 2018

Study Completion

May 15, 2019

Last Updated

May 9, 2017

Record last verified: 2017-05

Locations